Senior insider sale
VIKING THERAPEUTICS, INC. — senior position signals high conviction
$2.59M
42.49K shares
What this filing means
SINGLETON J MATTHEW plans to sell 42.49K shares of VIKING THERAPEUTICS, INC. valued at approximately $2.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2024ACC: 0000103623-24-000074
Director
Since Jan 2019
42.49K
Shares to sell
$2.59M
Approx. market value
5.70K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
NQSO
N/A
1/3/2017
5.70KTotal acquired5.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2017 | NQSO N/A | 5.70K | — |
| Total | 5.70K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
16K
Market value
$995.4K
8/19/2024
—Completed
Units to sell
20.79K
Market value
$1.20M
8/14/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.70K
Market value
$397.4K
8/21/2024
Total
Units
42.49K
Value
$2.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/19/2024 | 16K | $995.4K | — | Completed |
8/14/2024 | 20.79K | $1.20M | — | Completed |
| Planned — Approximate Date | ||||
8/21/2024 | 5.70K | $397.4K | NASDAQ | Planned |
| Total | 42.49K | $2.59M | ||